Caprelsa (Vandetanib Tablet) 300mg

Caprelsa (vandetanib) 300mg tablets are prescribed for adults with certain thyroid cancers. This targeted therapy helps manage symptoms and slow disease progression. Always follow your doctor’s guidance when using Caprelsa. Keep out of reach of children.

Strength

300mg

Manufacturer / TM Owner

Sanofi Aventis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Caprelsa (vandetanib) 300mg tablets are used to treat medullary thyroid cancer in adults when surgery is not possible. It belongs to a class of drugs called kinase inhibitors, which help slow tumor growth. This medication may also be used for other conditions as determined by a healthcare provider. Always use Caprelsa exactly as prescribed.

Side Effects

Caprelsa (vandetanib) 300mg tablets may help reduce symptoms such as neck pain or swelling over time. Some patients notice improved energy levels and reduced tumor-related discomfort. Effects vary by individual, and consistent use is important for best results. Regular monitoring by a doctor is recommended during treatment.

Precautions & Warnings

Caprelsa (vandetanib) 300mg tablets should be stored in a cool, dry place away from direct light. Keep the medication in its original packaging until ready to use. Avoid crushing or splitting tablets unless advised by a healthcare professional. Always check the expiration date before use.

Avoid Interactions

Caprelsa (vandetanib) 300mg tablets may interact with other medications, including certain antibiotics, antifungals, and heart drugs. Grapefruit and grapefruit juice can affect how the body processes this medication. Always inform your doctor about all prescription, over-the-counter, and herbal products you are using.

Frequently Asked Questions

Caprelsa (vandetanib) is used to treat medullary thyroid cancer in adults when surgery is not an option.

Take Caprelsa exactly as prescribed by your doctor, usually once daily with or without food.

Common side effects may include diarrhea, rash, nausea, and fatigue. Report any persistent issues to your healthcare provider.

Avoid grapefruit juice as it may increase the risk of side effects. Consult your doctor for personalized advice.

Caprelsa may harm an unborn baby. Use effective birth control during treatment and discuss family planning with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.